What's New

21 December 2011

Equine Gastrafate® Distribution Agreement

Bioniche has entered into a distribution agreement with U.S.-based Mueller Medical International LLC for exclusive distribution in North America of ... [read more]

---

21 December 2011

Celox™ Distribution Agreement

Bioniche has entered into a distribution agreement with UK-based MedTrade Products Limited for exclusive distribution in Canada of a number ... [read more]

---

27 October 2011

NexHA™ Receives Canadian Regulatory Approval

NexHA™, a low molecular weight hyaluronate sodium product for horses, has received approval from Health Canada’s Veterinary Drugs Directorate, and ... [read more]

---

29 September 2011

Bioniche Animal Health launches new global website

Welcome to the new Bioniche Animal Health global website !!   This site has been designed to give anyone, anywhere in the ... [read more]

---

26 September 2011

PERIDAN Concentrate now available in North America

PERIDAN™ Concentrate has been specifically developed to help reduce the formation of potentially dangerous post-surgical adhesions in horses. PERIDAN Concentrate is ... [read more]

---

19 September 2011

CUE-MARE now approved in Australia

Cue-Mare™ provides a convenient and cost-effective new option for inducing estrous in spring transitional mares, which is particularly important to enable ... [read more]

---

12 September 2011

TRI-OTIC launched in Australia

Tri-Otic™ Ointment is an effective, triple-action (anti-inflammatory, antifungal, antibacterial) product for combating painful ear infections in dogs.  This new economical ... [read more]

---

29 April 2011

Bioniche Vaccine Manufacturing Centre Officially Opens

Bioniche Life Sciences Inc. (TSX:BNC) (ASX:BNC), a research-based, technology-driven Canadian biopharmaceutical company, today officially opened its new Animal Health and ... [read more]